Antimicrobial resistance modulation of MDR E. coli by antibiotic coated ZnO nanoparticles

Muhammad Ahsan Anwar1, Amjad Islam Aqib2, Khurram Ashfaq1

  • 1Department of Clinical Medicine and Surgery, University of Agriculture, Faisalabad, 38000, Pakistan.

Microbial Pathogenesis
|August 28, 2020
PubMed

Insights

Antibiotic-coated zinc oxide nanoparticles (ZnO NPs) effectively combat multidrug-resistant E. coli. The combination of gentamicin and chloramphenicol on ZnO NPs demonstrated superior antimicrobial activity, offering a promising strategy against resistant bacterial infections.

Area of Science:

  • Nanotechnology
  • Microbiology
  • Veterinary Medicine

Background:

  • Multidrug-resistant (MDR) E. coli poses a significant threat in bovine mastitis.
  • Conventional antibiotics are becoming less effective against MDR bacterial strains.
  • Novel strategies are needed to overcome antibiotic resistance.

Purpose of the Study:

  • To evaluate the efficacy of antibiotic-coated zinc oxide nanoparticles (ZnO NPs) against MDR E. coli.
  • To compare the antimicrobial activity of different antibiotic-coated ZnO NP formulations with individual antibiotics and bare ZnO NPs.
  • To assess the potential of these nano-formulations in combating antibiotic resistance.

Main Methods:

  • Isolation and identification of MDR E. coli from bovine mastitic milk samples.
  • Synthesis and characterization of ZnO NPs and antibiotic-coated ZnO NPs (gentamicin-coated nanoparticle-GNp, chloramphenicol-coated nanoparticle-CNp, and gentamicin & chloramphenicol-coated nanoparticle-GCNp).
  • Determination of minimum inhibitory concentrations (MICs) and zone of inhibitions (ZOIs) for all preparations.

Main Results:

  • GCNp exhibited the lowest MICs and highest ZOIs, indicating superior efficacy against MDR E. coli.
  • Antibiotic-coated ZnO NPs showed significantly enhanced antimicrobial activity compared to individual antibiotics and bare ZnO NPs.
  • Highest bacterial filamentation, indicative of cell damage, was observed with GCNp.

Conclusions:

  • Antibiotic-coated ZnO NPs, particularly GCNp, are effective in modulating antibiotic resistance in MDR E. coli.
  • These nano-formulations represent promising therapeutic candidates for treating MDR bacterial infections.
  • The study highlights the potential of nanotechnology in addressing the challenge of antimicrobial resistance.